Disclaimer

The trademark information displayed on this page is public information and is provided for informational purposes only. This information may be incomplete, inaccurate, or outdated, and IndiaFilings does not guarantee its accuracy. IndiaFilings is an independent platform and is not associated, affiliated, or connected with any trademark listed in this database. We do not represent or speak on behalf of any such trademark. If you are trying to contact a specific trademark, please use their official channels. IndiaFilings cannot assist with queries directed at other companies.

AMCEBRO

Class 5Status: Accepted & Advertised
Application Number6125506
Trademark Status
Accepted & Advertised
Trademark Class5
Application Date2023-09-26
Proprietor NameAMAGEN INDIA LIFE SCIENCES
Appropriate OfficeAHMEDABAD
StateRAJASTHAN
Trademark TypeWORD
User DetailsProposed to be used
Agent NameASHOK KUMAR SHARMA[15625]
Agent Address0-26 third floor amber tower sansar chand road jaipur
Goods And Services Details[CLASS : 5] PHARMACEUTICAL AND MEDICINAL PREPARATION INCLUDED IN CLASS 5

Identical Trademarks

Similar trademarks found for this brand

1 found
BrandClassStatus
AMCEBRO5Accepted & Advertised
Showing up to 6 identical trademarksView more on LEDGERS→

Trademark Protection

Automate the monitoring of your trademark application and filing of response to Government Objection or Hearing.

₹9,899+ GST

What's included:

✓
Brand Guard ( 1 application 1 class)
✓
Appointment of Lawyer
✓
Objection
✓
Hearing
✓
Infringement support (1)
✓
Power of Attorney (POA)

Frequently asked questions

Common questions about AMCEBRO.

What is the status of trademark application 6125506?
The current status of trademark application 6125506 for AMCEBRO is Accepted & Advertised.
What is the trademark class of AMCEBRO?
AMCEBRO is registered under trademark class 5.
Who is the proprietor of AMCEBRO?
The proprietor of AMCEBRO is AMAGEN INDIA LIFE SCIENCES.
When was trademark application 6125506 filed?
Trademark application 6125506 for AMCEBRO was filed on 2023-09-26.